Adropin stimulate proliferation in mesenchymal-like MDA-MB-231 cells by MAPK/ERK1/2 signaling pathway which is essential for the upregulation of E-cadherin and accompanying phenotypic changes in human breast cancer cells (11). The gene discussed is MAPK3; the disease is breast cancer.